Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Botulinum Antitoxin Patient Registry for the Evaluation of Safety and Clinical Outcomes of Pediatric and Adult Patients Following BAT Treatment for Confirmed or Suspected Exposure to Botulinum Toxin.

NCT02055183 is registered in ClinicalTrials.gov with Emergent BioSolutions as lead sponsor.

NCT NCT02055183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02055183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Botulinum Antitoxin Patient Registry for the Evaluation of Safety and Clinical Outcomes of Pediatric and Adult Patients Following BAT Treatment for Confirmed or Suspected Exposure to Botulinum Toxin.
Lead sponsor
Emergent BioSolutions
Phase
Observational
Overall status
Completed
Start date
October 31, 2014
Completion date
July 31, 2017
Enrollment
162 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

botulism